“Measuring Antigen Specific T- cells using Surface and Intracellular Staining Polychromatic Flow...
-
Upload
caren-hicks -
Category
Documents
-
view
214 -
download
0
Transcript of “Measuring Antigen Specific T- cells using Surface and Intracellular Staining Polychromatic Flow...
“Measuring Antigen Specific T-cells using Surface and
Intracellular Staining Polychromatic Flow Cytometry”
3rd Annual CFAR Flow Cytometry Workshop6-10 May, 2013
Janet StaatsFlow Cytometry Core Facility
Center for AIDS ResearchDuke University Medical Center
E-mail: [email protected]
Part 1 of 3
Overview of PFC Assay
Duke University Medical Center
IL-4IL-2
TNFaIFNg
APC-T cellinteractions
Cytokine/Chemokineexpression
Rantes
Apoptosis
Proliferation/Death
Memory CD4 T Cell Response to Ag
From H. MaeckerDuke University Medical Center
CD4+
T cellcytokines
CD8+
CTL
APC MHCII
CD4
CD8 cytokines
Ag
peptide
MHC I
T, B,or APC
MHC I
Wholeprotein
Optimalpeptide
Duke University Medical CenterFrom H. Maecker
Response to CMV pp65 Peptide Mix
0.19% 2.03%
pp65 protein peptide mix A2 peptide
1.14%
CMV lysate
0.87%
CD8
7.41%0.27% 0.04%0.27%
CD4
Duke University Medical CenterFrom H. Maecker
Peptide Mixes15 a.a.
11 a.a.
CMV pp65: pool of 138 peptidesHIV p55: pool of 120 peptides
Duke University Medical Center
Sampson Clinical Trial:11-Color Maturation/Function Panel
Basic Subset Markers:• CD3 (T-cells)• CD4 (T-Helper Subset)• CD8 (T-Suppressor Subset)
Exclusion Markers:• CD14 (Monocytes)• CD19 (B-cells)• vAmine (Dead cell marker)
Maturational Markers:• CD45RO• CD27• CD57
Functional Markers:• CD107• IFN-• TNF• IL-2
Duke University Medical Center
Wash
5. Permeabilize
Wash
6. IC Stain7. Acquisition
8. Analysis
Overview of 11-Color Assay
4. Lyse/Fix
BrefeldinMonensin
3. Surface Stain2. Stimulate
Wash
lymphocyteerythrocyte
cytokine
6 hrs
AmineCD14 CD3CD4CD8
CD45ROCD27CD57
IFNIL2TNF
1. Thaw
Rest
CD1076 h
CostimSEB
CMVpp65
Wash
CD107 PE-Cy5
CD8+ CM Response
7+g+M+g+M+
M+
Monday Tuesday WednesdayThursday - Friday
Duke University Medical Center
FSC-W
FS
C-H
88.3
<V705-A>: CD8 Q705
<G
710-
A>
: CD
4 C
Y55
PE
57.8
36.3
0.79
FSC-A
SS
C-A
99.3
<Violet G-A>: CD3 Amcyan
<V
iole
t H-A
>: v
Am
ine
CD
14P
B C
D19
PB
41.4
Gating Strategy for 11-Color Maturation/Function Panel: 1 of 3
CD
4 P
erC
P-C
y5.5
SS
C-A
Exc
lusi
on
(V
iole
t H
)
FS
C-H
FSC-ACD3 AmCyanFSC-W
CD8 Alexa700
Ungated Singlets CD3+ Exclusion-
Scatter
Basic Gates:
CD4+CD8-
CD8+CD4-
CD4+CD8+
- 3 total
Duke University Medical Center
<G
660-
A>
: C
D27
CY
5PE
43 54.1
2.580.33
<G
660-
A>
: C
D27
CY
5PE
56.4 28.6
8.466.55
<V
545-
A>
: C
D57
Q54
5
0.12 1.07
55.942.9
<V
545-
A>
: C
D57
Q54
5
5.67 13.2
24.256.9
Gating Strategy for Sampson 11-Color Maturation/Function Panel: 2 of 3
<G
660-
A>
: C
D27
CY
5PE
22 62.5
11.73.98
<V
545-
A>
: C
D57
Q54
5
3.98 22.9
51.721.5
CD
57
FIT
C
CD
57
FIT
C
CD
57
FIT
CCD
27
AP
C-A
lex
a75
0
CD
27
AP
C-A
lex
a75
0
CD
27
AP
C-A
lex
a75
0
CD45RO ECD
N
N
N
CM
CM
CMEM
EM
EM
TE
TE
TE
E
E
E
Maturational Gates:
CD4+CD8-
CD8+CD4-
CD4+CD8+
CD45RO ECD
CD45RO ECD
NaiveCentral Memory
EffectorMemory
Terminal Effector
Effector
NaiveCentral Memory
EffectorMemory
Terminal Effector
Effector
NaiveCentral Memory
EffectorMemory
Terminal Effector
Effector
- 5 per basic subset
Duke University Medical Center
<R710-A>: CD107a AX680
2.59CD107
Gating Strategy for Sampson 11-Color Maturation/Function Panel: 3 of 3
Functional & Boolean Gates: - 4 functional gates per maturational subset - 16 boolean gates per maturational subset
CM: CD8+CD4-
Boolean Gates
Polyfunctional (1: ++++)
Polyfunctional (4: +++)
Bifunctional (6: ++)
Monofunctional (4: +)
Nonfunctional (1: ----)
Key:7 = CD107g = IFN-2 = IL-2T = TNF-
1.14
IL-2
TNF-
IFN-
0.31
4.19
Duke University Medical Center
Visualizing PFC Data:CMVpp65-specific Polyfunctional Response in CD8+ Central Memory Subset Increases
Post-Vaccination
Betts, (2006) Blood 107, 4781-4789.Makedonas, (2006) Springer Semin. Immunopathol. 28, 209-219.
Simplified Presentation of Incredibly Complex Evaluations
Dr. Mario RoedererImmunotechnology SectionVRC / NIAID / NIH
Duke University Medical Center
Part 2 of 3
PFC Challenges
Duke University Medical Center
Challenges…
• Instrument - optical configuration, optimization, standardization, and calibration
• Reagent - optimization and standardization
• Sample processing• Staining protocols• Data Analysis - compensation &
gating• Operators• Volume of data (death-by-excel!)
Duke University Medical Center
Consistency across batchesCD38 vs HLA-DR Staining on Ctrl 5L
28Feb085L CD8+
04Marb085L CD8+
11Mar085L CD8+
06Mar085L CD8+
Duke University Medical Center
uncompensated
compensationFSC/SSC settings
PMT settings
highlow
Difficulties in doing Automated Analysis related to Instrument Settings
CD4
CD
3
IFNg
CD
69
CD4
SS
C
FSC
SS
C
optimal optimal
Duke University Medical Center
Challenges…
• Instrument - optical configuration, optimization, standardization, and calibration
• Reagent - optimization and standardization
• Sample processing• Staining protocols• Data Analysis - compensation &
gating• Operators• Volume of data (death-by-excel!)
Duke University Medical Center
Optimization using Spillover Assessments: Using Titration Files to Assess Spreading Error
Violet G- CD3 AmCyan
<B
lue
B-A
><
Vio
let
H-A
><
Red
C-A
>
<R
ed B
-A>
Red
A-A
<G
reen
E-A
>
<G
reen
D-A
>
<G
reen
C-A
>
<G
reen
B-A
>
<G
reen
A-A
>
CD3AC (5ug/ml) Spillover assessment:
• After compensation CD3AC showed spilllover into Blue-B detector (FITC channel)
Blue Laser
Violet Laser
Red Laser
Green Laser
<B
lue
A-A
>
• Ottinger, et. al., Poster #28, 23rd Annual Clinical Cytometry Meeting (2008)• Mahnke, et. al. Clin Lab Med. 2007 September; 27(3): 469-v.• Lamoreaux, et. al., Nature Protocols 1, 1507-1516 (2006) on line 9 November 2006Duke University Medical Center
Spillover Assessments:CD3 AmCyan (5µg/mL) Spillover into CD27 (0.32µg/mL)
& CD57 FITC (1.8µg/mL)
• Spillover from CD3AC interferes with detection of dim CD27 pos cells
• Spillover from CD3AC does not
interfere with detection of CD57
• Spillover is acceptable if it does not interfere with proper classification of events
• mAb concentration may be varied to reduce spillover as long as frequency is unaffected
CD27 FITC
Blue B
SS
C
CD3AmCyan
9.8e-4Unstained
SS
C
0.047
Blue B
Unstained
66.3
4.58
0.13
CD57 FITC
CD3AmCyan
20.5
Duke University Medical Center
Is this positive???
CMV pp65 stimulated sample
Maecker, et. al.Duke University Medical Center
Tandems Degrade!
• Ice• Dark• Fix• Controls• 6 hours
Maecker, et. al.Duke University Medical Center
Challenges…
• Instrument - optical configuration, optimization, standardization, and calibration
• Reagent - optimization and standardization
• Sample processing• Staining protocols• Data Analysis - compensation &
gating• Volume of data (death-by-excel!) Duke University Medical Center
9-Color Activation/Maturation Using Cryo-preserved PBMC
Duke University Medical Center
Batch Processing ErrorCD38 vs HLA-DR Staining on Ctrl 5L
28Feb085L CD8+Lot 05262
04Marb085L CD8+Lot 05262
11Mar085L CD8+Lot 05262
06Mar085L CD8+Lot 05262
26Feb085L CD8+Lot 05262
Duke University Medical Center
Challenges…
• Instrument - optical configuration, optimization, standardization, and calibration
• Reagent - optimization and standardization
• Sample processing• Staining protocols• Data Analysis - compensation &
gating• Operator• Volume of data (death-by-excel!)
Duke University Medical Center
How would you gate?
Markers:CD3CD4CD8IL-2+IFNg(FSC)(SSC)
Duke University Medical Center
N CM EM TE E
Pre-Vaccination
33%
21%
27%
2%
17%
Post-Vaccination
8%
48%25%
2%
17%
Duke University Medical Center
Reproducible analysis allows us to measure an expansion of CD4+ CM cells post vaccination with
some degree of confidence
ICS Standardization Conclusions
• ICS assays can be performed by multiple laboratories using a common protocol with good inter-laboratory precision (<20% C.V.), that improves as the frequency of responding cells increases.
• Gating is a significant source of variability, and can be reduced by centralized analysis and/or use of standardized gating.
• Cryopreserved PBMC may yield slightly more consistent results than shipped whole blood.
• Use of pre-aliquoted lyophilized reagents for stimulation and staining can reduce variability.
BMC Immunology 2005, 6:13 http://www.biomedcentral.com/1471-2172/6/13 Duke University Medical Center
CIC ICS Gating Panel
110 labs participated and there were 110 different approaches to gating
BeforeBackgate
AfterBackgate
IFNgBackgate
CD3 AmCyan
Exc
lusi
on
0.38 5.74
CD4 Gated CD8 Gated
5.230.27
IFNg PE-Cy7
CD
4 P
erC
P-C
y5.5
CD
8 A
PC
-Cy7
BeforeBackgate
AfterBackgate
A
B
BACKGATING: purity & recovery
Duke University Medical Center
Gating bias in proficiency panel results
CD4 FITC
IL2+
IFN P
E
Unstim CEF CMV pp65
0.02%
0.01%
0.16%
0.03%
0.02%
0.17%
0.02%
0.03%
0.21%
Duke University Medical Center
We NEED better analysis tools!!!Manual (Expert) vs. Automated Analysis of
4-Color ICS Data File (CMVpp65)
0.21%0.18%
CD4 FITC
1.9%1.65%
CD8 PerCP-Cy5.5
IFN
- +
IL-2
PE
Expert GatingManual
Cluster GatingAutomated
Duke University Medical Center
Would you know a positive if you saw one?
Roederer. Cytometry Part A, 73A:384-385 (2008)Horton et. al. J Immuno Methods, 323:39-54 (2007)Maecker et. al. Cytometry Part A, 69A:1037-1042 (2006)Comin-Anduix et. al. Clin Cancer Res, 12(1):107-116 (2006)
2xSD?>0.05%?
OutsideNormal Range
RCV?
Duke University Medical Center
Challenges…
• Instrument - optical configuration, optimization, standardization, and calibration
• Reagent - optimization and standardization
• Sample processing• Staining protocols• Data Analysis - compensation &
gating• Operator• Volume of data (death-by-excel!)
Duke University Medical Center
Assay Complexity
Duke University Medical Center
Endpoints for 11-Color Maturation/Function Panel DEATH BY EXCEL ……..
Basic (3) Maturation (5) Function Boolean (16)
CD4+ CD8-
CD4+ CD8+
CD4- CD8+
NaïveCentral MemoryEffector MemoryEffectorTerminal Effector
CD107IFN-IL-2TNF-
Basic (3) Maturation (5) Boolean (16)X X 240/stim=X 3 Stimulations/Sample (CoStim, SEB, CMVpp65) = 720 Endpoints/Sample
720 Endpoints/Sample x 200 Samples (192 Participants + 8 Controls) = 144,000 Endpoints/Trial
Note 1: Frequency of parent only, reporting units of #cells/µL doubles the total EP/trialDuke University Medical Center
Data Annotation - for all 143,280 data points!
Study IDMethodAssay NameBatch #OperatorSample IDVisit IDAccession #% Viable (Flow)% Viable (Guava)RecoveryCD4 countCD8 countGate Name (Parameter Names)Tube NameFile NameError Code (1-11)
Checking:X1 - for electronic dataX3 - for manual entry
Requires STRONG statistical support:• Quickly exceeds limits of excel• Format data for statistical analysis
• FJ: column (gates) vs row (file)• CSV: column (identifiers) vs row (single value)
• Check data• Manual check: 8sec/value x 143280 = 49 days!!!
Duke University Medical Center
Part 3 of 3
Why does this matter??Why are you here???
Duke University Medical Center
Why is Reproducibility Important?
CFSE Standardization Results (13 EXPERT IM Labs):- Very high inter-laboratory variability.- High background in some laboratories.- Responses to Gag and Nef peptide pools were
detected in HIV negative (control) donors!
Example Gag stimulationHIV negative donor
Example CMVpp65 stimulationCMV positive donor
% C
D8
+ C
FS
E lo
w
LaboratoryDuke University Medical Center
History of Flow-based Proficiency/Standardization Efforts
Duke University Medical Center
The number of measurements outside the optimal range established by the GS was determined for each laboratory. Each laboratory performed a total of 54 measurements (27 for CD4+ cells and 27 for CD8+ cells). The red line represents 50% (=27) of the total measurements. Laboratories above this line had over 50% of their measurements outside the optimal range. The green line represents 20% of total measurements. The laboratories below this line had over 80% of their measurements within the optimal range.
ICS Proficiency Testing Results: March 2007
Duke University Medical Center
DAIDS ICS Proficiency:Round 6, 26Jun09 (CMVpp65)
CD4-CD8+ CD4+CD8-
IFN
g +
IL-2
PE
CD3 APC-Cy7
Rep #1
Rep #2
Rep #3
Duke University Medical Center
Acknowledgements
Duke University Medical Center
Duke CFARKent WeinholdJennifer EnzorTwan WeaverJianling ShiCliburn Chan
Patricia D’Souza (DAIDS) CFSE Standardization:
Claire Laundry (NIML)
EQAPOL
Duke Tisch Brain Tumor CenterGary ArcherDuane MitchellJohn Sampson
CHAVI
VRCSteve PerfettoLaurie LamoureauxMario Roederer
CVCSylvia Janetski
Duke DTRIScottie Sparks (Roche)